| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 607554 | 88295 | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA, 36 frascos de 50 ml | 20 mg/ml + 0,7 mg/ml | 6 | 1800 | 26 | 36 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88295/88295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88295/88295_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 45555 | 45555 | 2022-11-21 | 1 | 1 | 1 | 2022-11-22 | 2022-11-21 | 1 | 2023-02-24 | View Edit Delete | ||||||||||||
| 607555 | 88295 | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA, 15 frascos de 250 ml | 20 mg/ml + 0,7 mg/ml | 6 | 3750 | 26 | 15 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88295/88295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88295/88295_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 45555 | 45555 | 2022-11-21 | 1 | 1 | 1 | 2022-11-22 | 2022-11-21 | 1 | 2023-02-24 | View Edit Delete | ||||||||||||
| 607605 | 88409 | AQUASEPTIC PHARMA ORANGE 20 MG/ML SOLUCIÓN CUTÁNEA | AQUASEPTIC PHARMA ORANGE 20 MG/ML SOLUCIÓN CUTÁNEA, 36 frascos de 50 ml | 20 mg/ml | 6 | 1800 | 26 | 36 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88409/88409_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88409/88409_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 45555 | 45555 | 2022-12-22 | 1 | 1 | 1 | 2022-12-23 | 2022-12-22 | 1 | 2023-02-24 | View Edit Delete | ||||||||||||
| 607611 | 88467 | QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA | QUIROCROM 20 MG/ML + 0,70 ML/ML SOLUCION CUTANEA, 15 frascos | 20 mg/ml + 0,70 mg/ml | 6 | 3750 | 26 | 15 frascos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88467/88467_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88467/88467_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | 2513 | 2022-12-28 | 1 | 1 | 1 | 2022-12-29 | 2022-12-28 | 1 | 2023-01-31 | View Edit Delete | ||||||||||||
| 607827 | 88295 | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA | BACTISEPTIC PHARMA ORANGE 20 MG/ML + 0,70 ML/ML SOLUCIÓN CUTÁNEA, 15 frascos de 500 ml | 20 mg/ml + 0,7 mg/ml | 6 | 7500 | 26 | 15 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88295/88295_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88295/88295_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 45555 | 45555 | 2022-11-21 | 1 | 1 | 1 | 2022-11-22 | 2024-09-13 | 1 | 2024-10-09 | View Edit Delete | ||||||||||||
| 651474 | 66868 | ALGIDRIN INFANTIL 200 mg POLVO PARA SUSPENSION ORAL | ALGIDRIN INFANTIL 200 mg POLVO PARA SUSPENSION ORAL, 20 sobres | 200 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66868/66868_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66868/66868_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | 27143 | 2005-06-06 | 1 | 1 | 1 | 2005-06-06 | 2005-06-06 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659434 | 69037 | TOPIRAMATO VIATRIS 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | TOPIRAMATO VIATRIS 200 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidos | 200 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69037/69037_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69037/69037_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44524 | 44524 | 2007-06-26 | 1 | 1 | 1 | 2007-06-26 | 2007-06-26 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660917 | 08451002 | VOLIBRIS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VOLIBRIS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08451002/08451002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08451002/08451002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30530 | 3732 | 2008-05-07 | 1 | 1 | 1 | 2008-05-07 | 2008-05-07 | 1 | 2011-09-19 | View Edit Delete | ||||||||||||
| 662423 | 08451004 | VOLIBRIS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | VOLIBRIS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08451004/08451004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08451004/08451004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30530 | 3732 | 2009-04-23 | 1 | 1 | 1 | 2009-04-23 | 2009-04-23 | 1 | 2011-02-21 | View Edit Delete | ||||||||||||
| 674662 | 72705 | FENOFIBRATO TEVA 200 mg CAPSULAS DURAS EFG | FENOFIBRATO TEVA 200 mg CAPSULAS DURAS EFG , 30 cápsulas | 200 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72705/72705_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72705/72705_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | 34492 | 2011-05-16 | 1 | 1 | 1 | 2011-05-16 | 2011-05-16 | 1 | 2012-04-03 | View Edit Delete | ||||||||||||
| 683845 | 74686 | GALANTAMINA VIATRIS 8 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | GALANTAMINA VIATRIS 8 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 28 cápsulas | 8 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74686/74686_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74686/74686_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2012-10-08 | 1 | 1 | 1 | 2012-10-08 | 2012-10-08 | 1 | 2013-05-02 | View Edit Delete | ||||||||||||
| 683866 | 74687 | GALANTAMINA VIATRIS 16 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | GALANTAMINA VIATRIS 16 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 28 cápsulas | 16 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74687/74687_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74687/74687_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2012-10-08 | 1 | 1 | 1 | 2012-10-08 | 2012-10-08 | 1 | 2013-05-02 | View Edit Delete | ||||||||||||
| 683885 | 74688 | GALANTAMINA VIATRIS 24 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | GALANTAMINA VIATRIS 24 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 28 cápsulas | 24 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74688/74688_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74688/74688_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 38105 | 38815 | 2012-10-08 | 1 | 1 | 1 | 2012-10-08 | 2012-10-08 | 1 | 2013-05-02 | View Edit Delete | ||||||||||||
| 692740 | 76354 | LEVOBEL 0.10 MG/0.02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVOBEL 0.10 MG/0.02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 21 comprimidos | 0,1 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76354/76354_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76354/76354_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2012-12-19 | 1 | 1 | 1 | 2012-12-19 | 2012-12-19 | 1 | 2013-04-04 | View Edit Delete | ||||||||||||
| 692741 | 76354 | LEVOBEL 0.10 MG/0.02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVOBEL 0.10 MG/0.02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 63 (3 x 21) comprimidos | 0,1 mg/0,02 mg | 5 | 63 | 10 | 63 (3 x 21) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76354/76354_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76354/76354_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2012-12-19 | 1 | 1 | 1 | 2012-12-19 | 2012-12-19 | 1 | 2013-04-04 | View Edit Delete | ||||||||||||
| 692743 | 76355 | LEVOBEL DIARIO 0.10 MG/0.02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVOBEL DIARIO 0.10 MG/0.02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 0,1 mg/0,02 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76355/76355_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76355/76355_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2012-12-19 | 1 | 1 | 1 | 2012-12-19 | 2012-12-19 | 1 | 2013-04-04 | View Edit Delete | ||||||||||||
| 692744 | 76355 | LEVOBEL DIARIO 0.10 MG/0.02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVOBEL DIARIO 0.10 MG/0.02 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 84 (3 x 28) comprimidos | 0,1 mg/0,02 mg | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76355/76355_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76355/76355_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | 7216 | 2012-12-19 | 1 | 1 | 1 | 2012-12-19 | 2012-12-19 | 1 | 2013-04-04 | View Edit Delete | ||||||||||||
| 693651 | 76603 | VENLAFAXINA SUN 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA | VENLAFAXINA SUN 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 150 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76603/76603_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76603/76603_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | 34173 | 2012-10-08 | 1 | 1 | 1 | 2021-01-12 | 2021-01-12 | 1 | 2018-04-12 | View Edit Delete | ||||||||||||
| 693661 | 76604 | VENLAFAXINA SUN 75 MG COMPRIMIDOS DE LIBERACION PROLONGADA | VENLAFAXINA SUN 75 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 75 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76604/76604_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76604/76604_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | 34173 | 2012-10-08 | 1 | 1 | 1 | 2017-07-06 | 2017-07-06 | 1 | 2018-04-12 | View Edit Delete | ||||||||||||
| 696134 | 76928 | CLOPIDOGREL PHARMA COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CLOPIDOGREL PHARMA COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 Comprimidos (AL/AL) | 75 mg | 5 | 28 | 10 | 28 Comprimidos (AL/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76928/76928_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76928/76928_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2012-12-21 | 1 | 1 | 1 | 2012-12-21 | 2013-01-22 | 1 | 2013-10-31 | View Edit Delete | ||||||||||||
| 696135 | 76928 | CLOPIDOGREL PHARMA COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CLOPIDOGREL PHARMA COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 50 comprimidos (AL/AL) | 75 mg | 5 | 50 | 10 | 50 comprimidos (AL/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76928/76928_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76928/76928_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2012-12-21 | 1 | 1 | 1 | 2012-12-21 | 2013-01-22 | 1 | 2013-10-31 | View Edit Delete | ||||||||||||
| 702772 | 78859 | ALGIDRIN PEDIATRICO 20 MG/ML SUSPENSION ORAL | ALGIDRIN PEDIATRICO 20 MG/ML SUSPENSION ORAL , 200 ml | 20 mg/ml | 6 | 200 | 26 | 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78859/78859_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78859/78859_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | 27143 | 2014-06-30 | 1 | 1 | 1 | 2014-06-30 | 2014-06-30 | 1 | 2015-04-17 | View Edit Delete | ||||||||||||
| 703500 | 79022 | LEVODOPA/CARBIDOPA/ENTACAPONA TEVA-RATIOPHARM 100/25/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA TEVA-RATIOPHARM 100/25/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 100 comprimidos | 50 mg/12,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79022/79022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79022/79022_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2014-09-08 | 1 | 1 | 1 | 2014-09-08 | 2014-09-08 | 1 | 2014-12-12 | View Edit Delete | ||||||||||||
| 705801 | 79647 | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 100 MG/25 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 100 MG/25 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 100 mg/25 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79647/79647_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79647/79647_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2015-05-25 | View Edit Delete | ||||||||||||
| 705804 | 79650 | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 100 mg/25 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 100 mg/25 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidos | 100 mg/25 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79650/79650_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79650/79650_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2017-06-15 | View Edit Delete | ||||||||||||
| 710830 | 78433 | TERMALGIN RESFRIADO 500 MG/30 MG POLVO PARA SOLUCION ORAL | TERMALGIN RESFRIADO 500 MG/30 MG POLVO PARA SOLUCION ORAL, 10 sobres | 500 mg/30 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78433/78433_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78433/78433_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71217 | 71217 | 2014-02-03 | 1 | 1 | 1 | 2016-05-18 | 2016-05-18 | 1 | 2016-09-15 | View Edit Delete | ||||||||||||
| 720207 | 1171209029 | REAGILA 6 MG CAPSULAS DURAS | REAGILA 6 MG CAPSULAS DURAS, 28 cápsulas | 6 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171209029/1171209029_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171209029/1171209029_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | 15657 | 2018-02-12 | 1 | 1 | 1 | 2018-02-13 | 2018-02-12 | 1 | 2019-06-25 | View Edit Delete | ||||||||||||
| 720209 | 1171209021 | REAGILA 4,5 MG CAPSULAS DURAS | REAGILA 4,5 MG CAPSULAS DURAS, 28 cápsulas | 4,5 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171209021/1171209021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171209021/1171209021_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | 15657 | 2018-02-12 | 1 | 1 | 1 | 2018-02-13 | 2018-02-12 | 1 | 2019-06-25 | View Edit Delete | ||||||||||||
| 720212 | 1171209011 | REAGILA 3 MG CAPSULAS DURAS | REAGILA 3 MG CAPSULAS DURAS, 28 cápsulas | 3 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171209011/1171209011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171209011/1171209011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | 15657 | 2018-02-12 | 1 | 1 | 1 | 2018-02-13 | 2018-02-12 | 1 | 2019-06-25 | View Edit Delete | ||||||||||||
| 723410 | 83373 | VENLAFAXINA RETARD PENSA PHARMA 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD PENSA PHARMA 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas (Blister PVC/PVDC/Al) | 150 mg | 5 | 30 | 43 | 30 cápsulas (Blister PVC/PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83373/83373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83373/83373_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2018-08-08 | 1 | 1 | 1 | 2018-08-09 | 2018-08-08 | 1 | 2019-04-10 | View Edit Delete | ||||||||||||
| 724778 | 83825 | AMOXICILINA ALTER 500 MG CAPSULAS DURAS EFG | AMOXICILINA ALTER 500 MG CAPSULAS DURAS EFG, 20 cápsulas | 500 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83825/83825_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83825/83825_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2019-02-12 | 1 | 1 | 1 | 2019-02-13 | 2019-02-12 | 1 | 2020-07-23 | View Edit Delete | ||||||||||||
| 724779 | 83825 | AMOXICILINA ALTER 500 MG CAPSULAS DURAS EFG | AMOXICILINA ALTER 500 MG CAPSULAS DURAS EFG, 30 cápsulas | 500 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83825/83825_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83825/83825_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | 137 | 2019-02-12 | 1 | 1 | 1 | 2019-02-13 | 2019-02-12 | 1 | 2020-07-23 | View Edit Delete | ||||||||||||
| 725905 | 84173 | AMOXICILINA PENSA PHARMA 500 MG CAPSULAS DURAS EFG | AMOXICILINA PENSA PHARMA 500 MG CAPSULAS DURAS EFG, 20 cápsulas | 500 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84173/84173_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84173/84173_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2019-05-30 | 1 | 1 | 1 | 2019-05-31 | 2019-05-30 | 1 | 2021-07-02 | View Edit Delete | ||||||||||||
| 725906 | 84173 | AMOXICILINA PENSA PHARMA 500 MG CAPSULAS DURAS EFG | AMOXICILINA PENSA PHARMA 500 MG CAPSULAS DURAS EFG, 30 cápsulas | 500 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84173/84173_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84173/84173_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | 40831 | 2019-05-30 | 1 | 1 | 1 | 2019-05-31 | 2019-05-30 | 1 | 2021-07-02 | View Edit Delete | ||||||||||||
| 726432 | 76928 | CLOPIDOGREL PHARMA COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CLOPIDOGREL PHARMA COMBIX 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG,84 comprimidos | 75 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76928/76928_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76928/76928_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2012-12-21 | 1 | 1 | 1 | 2012-12-21 | 2019-07-23 | 1 | 2019-10-22 | View Edit Delete | ||||||||||||
| 726475 | 84392 | VENLAFAXINA RETARD SANDOZ 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD SANDOZ 150 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 150 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84392/84392_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84392/84392_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2019-07-29 | 1 | 1 | 1 | 2019-07-30 | 2019-07-29 | 1 | 2021-01-14 | View Edit Delete | ||||||||||||
| 726820 | 84486 | AMOXICILINA TARBIS FARMA 500 MG CAPSULAS DURAS EFG | AMOXICILINA TARBIS FARMA 500 MG CAPSULAS DURAS EFG, 20 cápsulas | 500 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84486/84486_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84486/84486_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2019-09-27 | 1 | 1 | 1 | 2019-09-28 | 2019-09-27 | 1 | 2020-06-15 | View Edit Delete | ||||||||||||
| 726821 | 84486 | AMOXICILINA TARBIS FARMA 500 MG CAPSULAS DURAS EFG | AMOXICILINA TARBIS FARMA 500 MG CAPSULAS DURAS EFG, 30 cápsulas | 500 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84486/84486_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84486/84486_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | 2876 | 2019-09-27 | 1 | 1 | 1 | 2019-09-28 | 2019-09-27 | 1 | 2020-06-15 | View Edit Delete | ||||||||||||
| 727273 | 84607 | CONFEROPORT 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 30 cápsulas | 0,5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84607/84607_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84607/84607_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2019-11-12 | 1 | 1 | 1 | 2019-11-12 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727324 | 84629 | CONFEROPORT 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 1 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84629/84629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84629/84629_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727325 | 84629 | CONFEROPORT 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 60 cápsulas | 1 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84629/84629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84629/84629_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727326 | 84630 | CONFEROPORT 2 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | CONFEROPORT 2 MG CAPSULAS DURAS DE LIBERACION PROLONGADA , 30 cápsulas | 2 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84630/84630_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84630/84630_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727327 | 84631 | CONFEROPORT 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 3 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84631/84631_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84631/84631_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727328 | 84632 | CONFEROPORT 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84632/84632_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84632/84632_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727346 | 84644 | ALGIDRIN PEDIATRICO 40 MG/ML SUSPENSION ORAL | ALGIDRIN PEDIATRICO 40 MG/ML SUSPENSION ORAL, 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84644/84644_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84644/84644_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27143 | 27143 | 2019-11-14 | 1 | 1 | 1 | 2019-11-15 | 2019-11-14 | 1 | 2020-09-29 | View Edit Delete | ||||||||||||
| 728474 | 04307004IP3 | ZONEGRAN 100 mg CAPSULAS DURAS | ZONEGRAN 100 mg CAPSULAS DURAS, 56 cápsulas | 100 mg | 5 | 56 | 43 | 56 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04307004IP3/04307004IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04307004IP3/04307004IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8130 | 26669 | 2020-05-08 | 1 | 1 | 1 | 2020-05-09 | 2020-05-08 | 1 | 2020-06-22 | View Edit Delete | ||||||||||||
| 729842 | 85593 | LENALIDOMIDA STADA 10 MG CAPSULAS DURAS EFG | LENALIDOMIDA STADA 10 MG CAPSULAS DURAS EFG, 21 cápsulas | 10 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85593/85593_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85593/85593_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2020-11-27 | 1 | 1 | 1 | 2020-11-28 | 2020-11-27 | 1 | 2022-01-12 | View Edit Delete | ||||||||||||
| 729844 | 85594 | LENALIDOMIDA STADA 15 MG CAPSULAS DURAS EFG | LENALIDOMIDA STADA 15 MG CAPSULAS DURAS EFG, 21 cápsulas | 15 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85594/85594_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85594/85594_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2020-11-27 | 1 | 1 | 1 | 2020-11-28 | 2020-11-27 | 1 | 2022-01-12 | View Edit Delete | ||||||||||||
| 729846 | 85595 | LENALIDOMIDA STADA 20 MG CAPSULAS DURAS EFG | LENALIDOMIDA STADA 20 MG CAPSULAS DURAS EFG, 21 cápsulas | 20 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85595/85595_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85595/85595_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2020-11-27 | 1 | 1 | 1 | 2020-11-28 | 2020-11-27 | 1 | 2022-01-12 | View Edit Delete | ||||||||||||
| 731078 | 85988 | BIJUVA 1 MG/100 MG CAPSULAS BLANDAS | BIJUVA 1 MG/100 MG CAPSULAS BLANDAS, 28 cápsulas | 100 mg/1 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85988/85988_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85988/85988_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2021-09-26 | View Edit Delete | ||||||||||||
| 731079 | 85988 | BIJUVA 1 MG/100 MG CAPSULAS BLANDAS | BIJUVA 1 MG/100 MG CAPSULAS BLANDAS, 84 cápsulas | 100 mg/1 mg | 5 | 84 | 43 | 84 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85988/85988_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85988/85988_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | 36570 | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2021-09-26 | View Edit Delete | ||||||||||||
| 731348 | 86090 | AMBRISENTAN SALA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMBRISENTAN SALA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (PVC/PVDC/Al) | 10 mg | 5 | 30 | 10 | 30 comprimidos (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86090/86090_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86090/86090_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | 2367 | 2021-07-14 | 1 | 1 | 1 | 2021-07-15 | 2021-07-14 | 1 | 2022-02-14 | View Edit Delete | ||||||||||||
| 731351 | 86091 | AMBRISENTAN SALA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMBRISENTAN SALA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (PVC/PVDC/Al) | 5 mg | 5 | 30 | 10 | 30 comprimidos (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86091/86091_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86091/86091_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | 2367 | 2021-07-14 | 1 | 1 | 1 | 2021-07-15 | 2021-07-14 | 1 | 2022-02-14 | View Edit Delete | ||||||||||||
| 756029 | 87837 | IBUPROFENO RAPID STADAPHARM 400 MG CAPSULAS BLANDAS | IBUPROFENO RAPID STADAPHARM 400 MG CAPSULAS BLANDAS, 20 cápsulas | 400 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87837/87837_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87837/87837_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-06-16 | 1 | 1 | 1 | 2022-06-17 | 2022-06-16 | 1 | 2023-08-02 | View Edit Delete | ||||||||||||
| 758235 | 88078 | TACROLIMUS STADAFARMA 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | TACROLIMUS STADAFARMA 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 0,5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88078/88078_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88078/88078_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-09-12 | 1 | 1 | 1 | 2022-09-13 | 2022-09-12 | 1 | 2023-03-30 | View Edit Delete | ||||||||||||
| 758237 | 88079 | TACROLIMUS STADAFARMA 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | TACROLIMUS STADAFARMA 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 60 cápsulas | 1 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88079/88079_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88079/88079_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-09-12 | 1 | 1 | 1 | 2022-09-13 | 2022-09-12 | 1 | 2023-03-30 | View Edit Delete | ||||||||||||
| 758238 | 88080 | TACROLIMUS STADAFARMA 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | TACROLIMUS STADAFARMA 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 3 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88080/88080_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88080/88080_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-09-12 | 1 | 1 | 1 | 2022-09-13 | 2022-09-12 | 1 | 2023-03-30 | View Edit Delete | ||||||||||||
| 758239 | 88081 | TACROLIMUS STADAFARMA 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | TACROLIMUS STADAFARMA 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88081/88081_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88081/88081_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2022-09-12 | 1 | 1 | 1 | 2022-09-13 | 2022-09-12 | 1 | 2023-03-30 | View Edit Delete | ||||||||||||
| 760591 | 88445 | AMBRISENTAN AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMBRISENTAN AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88445/88445_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88445/88445_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2023-03-15 | 1 | 1 | 1 | 2023-03-15 | 2023-03-15 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 760596 | 88446 | AMBRISENTAN AUROVITAS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMBRISENTAN AUROVITAS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88446/88446_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88446/88446_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16109 | 16109 | 2023-03-15 | 1 | 1 | 1 | 2023-03-15 | 2023-03-15 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762471 | 88756 | BONJESTA 20 MG/20 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA | BONJESTA 20 MG/20 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA, 10 comprimidos | 20 mg/20 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88756/88756_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88756/88756_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2023-04-04 | 1 | 1 | 1 | 2023-04-05 | 2023-04-04 | 1 | 2023-06-08 | View Edit Delete | ||||||||||||
| 762472 | 88756 | BONJESTA 20 MG/20 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA | BONJESTA 20 MG/20 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA, 20 comprimidos | 20 mg/20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88756/88756_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88756/88756_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23901 | 23901 | 2023-04-04 | 1 | 1 | 1 | 2023-04-05 | 2023-04-04 | 1 | 2023-06-08 | View Edit Delete | ||||||||||||
| 763976 | 88588 | COLECALCIFEROL STADA 25.000 UI CÁPSULAS BLANDAS | COLECALCIFEROL STADA 25.000 UI CÁPSULAS BLANDAS, 4 cápsulas | 25.000 UI | 5 | 4 | 43 | 4 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88588/88588_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88588/88588_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2024-01-04 | 1 | 1 | 1 | 2024-01-04 | 2024-01-04 | 1 | 2026-04-29 | View Edit Delete | ||||||||||||
| 764217 | 89305 | VENLAFAXINA RETARD NORMOGEN 150 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA EFG | VENLAFAXINA RETARD NORMOGEN 150 MG CÁPSULAS DURAS DE LIBERACIÓN PROLONGADA EFG, 30 cápsulas (Al/PVC/PVDC) | 150 mg | 5 | 30 | 43 | 30 cápsulas (Al/PVC/PVDC) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89305/89305_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89305/89305_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2024-02-07 | 1 | 1 | 1 | 2024-02-08 | 2024-02-07 | 1 | 2024-04-26 | View Edit Delete | ||||||||||||
| 764434 | 89399 | MEMANTINA FLAS COMBIX 10 MG COMPRIMIDOS BUCODISPERSABLE EFG | MEMANTINA FLAS COMBIX 10 MG COMPRIMIDOS BUCODISPERSABLE EFG, 112 comprimidos | 10 mg | 5 | 112 | 10 | 112 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89399/89399_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89399/89399_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2024-02-28 | 1 | 1 | 1 | 2024-02-29 | 2024-02-28 | 1 | 2024-07-05 | View Edit Delete | ||||||||||||
| 764435 | 89400 | MEMANTINA FLAS COMBIX 20 MG COMPRIMIDOS BUCODISPERSABLE EFG | MEMANTINA FLAS COMBIX 20 MG COMPRIMIDOS BUCODISPERSABLE EFG, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89400/89400_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89400/89400_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2024-02-28 | 1 | 1 | 1 | 2024-02-29 | 2024-02-28 | 1 | 2024-07-17 | View Edit Delete | ||||||||||||
| 765240 | 1241827002 | FRUZAQLA 5 MG CAPSULAS DURAS | FRUZAQLA 5 MG CAPSULAS DURAS, 21 cápsulas | 5 mg | 6 | 21 | 43 | 21 cápsulas | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241827002/1241827002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241827002/1241827002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 42050 | 70973 | 2024-06-26 | 1 | 1 | 1 | 2024-06-27 | 2024-06-26 | 1 | 2024-11-26 | View Edit Delete | ||||||||||||
| 765700 | 1241845022 | NILOTINIB ACCORD 200 MG CAPSULAS DURAS EFG | NILOTINIB ACCORD 200 MG CAPSULAS DURAS EFG, 112 cápsulas (4 envases x 28 cápsulas) | 200 mg | 5 | 112 | 43 | 112 cápsulas (4 envases x 28 cápsulas) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241845022/1241845022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241845022/1241845022_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11104 | 11104 | 2024-09-11 | 1 | 1 | 1 | 2024-09-12 | 2024-09-11 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 765895 | 89725 | HIDROFEROL SEMANAL 100 MICROGRAMOS CAPSULAS BLANDAS | HIDROFEROL SEMANAL 100 MICROGRAMOS CAPSULAS BLANDAS, 4 cápsulas | 100 microgramos | 5 | 4 | 43 | 4 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89725/89725_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89725/89725_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41329 | 41329 | 2024-10-03 | 1 | 1 | 1 | 2024-10-03 | 2024-10-03 | 1 | 2025-07-29 | View Edit Delete | ||||||||||||
| 767508 | 90290 | NILOTINIB ZENTIVA 200 MG CAPSULAS DURAS EFG | NILOTINIB ZENTIVA 200 MG CAPSULAS DURAS EFG, 112 cápsulas (4 envases x 28 cápsulas) | 200 mg | 5 | 112 | 43 | 112 cápsulas (4 envases x 28 cápsulas) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90290/90290_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90290/90290_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8183 | 69439 | 2025-07-09 | 1 | 1 | 1 | 2025-07-09 | 2025-07-09 | 1 | 2026-01-14 | View Edit Delete |